Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway

Nature Cell Biology

Volumn 17, Issue 4, 2015, Pages 500-510

  Mo, Jung Soon ^a   Meng, Zhipeng ^a   Kim, Young Chul ^b   Park, Hyun Woo ^a   Hansen, Carsten Gram ^a   Kim, Soohyun ^a   Lim, Dae Sik ^c   Guan, Kun Liang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LONG ACTING THYROID STIMULATOR; METFORMIN; PROTEIN HIPPO; PROTEIN TEAD; SERINE; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN; DNA BINDING PROTEIN; HIPPO PROTEIN, HUMAN; LATS1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PHOSPHOPROTEIN; PRKAA1 PROTEIN, HUMAN; PRKAA2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SMALL INTERFERING RNA; TAZ PROTEIN, HUMAN; TEAD1 PROTEIN, HUMAN; YAP1 (YES-ASSOCIATED) PROTEIN, HUMAN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL ENERGY; CELLULAR ENERGY STRESS; CELLULAR PARAMETERS; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME REGULATION; HUMAN; HUMAN CELL; MALE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NULL CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SOLID TUMOR; TUMOR XENOGRAFT; 3T3 CELL LINE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CELL TRANSFORMATION; CYTOPLASM; ENERGY METABOLISM; GENETICS; HEK293 CELL LINE; HELA CELL LINE; METABOLISM; NUDE MOUSE; PHOSPHORYLATION; RNA INTERFERENCE;

3T3 CELLS; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; CYTOPLASM; DNA-BINDING PROTEINS; ENERGY METABOLISM; ENZYME ACTIVATION; HEK293 CELLS; HELA CELLS; HUMANS; MICE; MICE, NUDE; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS;

EID: 84925970129     PISSN: 14657392     EISSN: 14764679     Source Type: Journal    
DOI: 10.1038/ncb3111     Document Type: Article

References (51)

1. Oh, H. & Irvine, K. D. Yorkie: the final destination of Hippo signaling. Trends Cell Biol. 20, 410-417 (2010).
2. Pan, D. The Hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505 (2010).
3. Zhao, B., Tumaneng, K. & Guan, K. L. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat. Cell Biol. 13, 877-883 (2011).
4. Zhao, B. et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747-2761 (2007).
5. Dong, J. et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120-1133 (2007).
6. Hao, Y., Chun, A., Cheung, K., Rashidi, B. & Yang, X. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J. Biol. Chem. 283, 5496-5509 (2008).
7. Zhao, B., Li, L., Tumaneng, K., Wang, C. Y. & Guan, K. L. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF-TRCP. Genes Dev. 24, 72-85 (2010).
8. Liu, C. Y. et al. The Hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCFf-g-TrCP E3 ligase. J. Biol. Chem. 285, 37159-37169 (2010).
9. Lu, L. et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc. Natl Acad. Sci. USA 107, 1437-1442 (2010).
10. Cai, J. et al. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 24, 2383-2388 (2010).
11. Lee, K. P. et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc. Natl Acad. Sci. USA 107, 8248-8253 (2010).
12. Ota, M. & Sasaki, H. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling. Development 135, 4059-4069 (2008).
13. Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962-1971 (2008).
14. Halder, G. & Johnson, R. L. Hippo signaling: growth control and beyond. Development 138, 9-22 (2011).
15. Harvey, K. F., Zhang, X. & Thomas, D. M. The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246-257 (2013).
16. Johnson, R. & Halder, G. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat. Rev. Drug Discov. 13, 63-79 (2014).
17. Strano, S. et al. The transcriptional coactivator Yes-Associated protein drives p73 gene-Target specificity in response to DNA damage. Mol. Cell 18, 447-459 (2005).
18. Lapi, E. et al. PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol. Cell 32, 803-814 (2008).
19. Cottini, F. et al. Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers. Nat. Med. 20, 599-606 (2014).
20. Schlegelmilch, K. et al. Yap1 acts downstream of-catenin to control epidermal proliferation. Cell 144, 782-795 (2011).
21. Zhao, B. et al. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 26, 54-68 (2012).
22. Yu, F. X. et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780-791 (2012).
23. Mo, J. S., Yu, F. X., Gong, R., Brown, J. H. & Guan, K. L. Regulation of the Hippo-YAP pathway by protease-Activated receptors (PARs). Genes Dev. 26, 2138-2143 (2012).
24. Miller, E. et al. Identification of serum-derived sphingosine-1-phosphate as a small molecule regulator of YAP. Chem. Biol. 19, 955-962 (2012).
25. Yu, F. X. et al. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev. 27, 1223-1232 (2013).
26. Dupont, S. et al. Role of YAP/TAZ in mechanotransduction. Nature 474, 179-183 (2011).
27. Wada, K., Itoga, K., Okano, T., Yonemura, S. & Sasaki, H. Hippo pathway regulation by cell morphology and stress fibers. Development 138, 3907-3914 (2011).
28. Sansores-Garcia, L. et al. Modulating F-Actin organization induces organ growth by affecting the Hippo pathway. EMBO J. 30, 2325-2335 (2011).
29. Hardie, D. G. AMP-Activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 25, 1895-1908 (2011).
30. Vassilev, A., Kaneko, K. J., Shu, H., Zhao, Y. & DePamphilis, M. L. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-Associated protein localized in the cytoplasm. Genes Dev. 15, 1229-1241 (2001).
31. Mahoney, W. M. Jr, Hong, J. H., Yaffe, M. B. & Farrance, I. K. The transcriptional coactivator TAZ interacts differentially with transcriptional enhancer factor-1 (TEF-1) family members. Biochem. J. 388, 217-225 (2005).
32. Tian, W., Yu, J., Tomchick, D. R., Pan, D. & Luo, X. Structural and functional analysis of the YAP-binding domain of human TEAD2. Proc. Natl Acad. Sci. USA 107, 7293-7298 (2010).
33. Chan, E. H. et al. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24, 2076-2086 (2005).
34. Praskova, M., Xia, F. & Avruch, J. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr. Biol. 18, 311-321 (2008).
35. Knowler, W. C. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346, 393-403 (2002).
36. Zhou, G. et al. Role of AMP-Activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174 (2001).
37. Evans, J. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R. & Morris, A. D. Metformin and reduced risk of cancer in diabetic patients. BMJ 330, 1304-1305 (2005).
38. Stambolic, V., Woodgett, J. R., Fantus, I. G., Pritchard, K. I. & Goodwin, P. J. Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?.Breast Cancer Res. Treat. 114, 387-389 (2009).
39. Moreno, D., Knecht, E., Viollet, B. & Sanz, P. A769662, a novel activator of AMPactivated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism. FEBS Lett. 582, 2650-2654 (2008).
40. Zhou, D. et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16, 425-438 (2009).
41. Sorrentino, G. et al. Metabolic control of YAP and TAZ by the mevalonate pathway. Nat. Cell Biol. 16, 357-366 (2014).
42. Kim, M. et al. cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes. EMBO J. 32, 1543-1555 (2013).
43. Inoki, K., Zhu, T. & Guan, K. L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577-590 (2003).
44. Kim, J., Kundu, M., Viollet, B. & Guan, K. L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132-141 (2011).
45. Budanov, A. V. & Karin, M. p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell 134, 451-460 (2008).
46. Li, Z. et al. Structural insights into the YAP and TEAD complex. Genes Dev. 24, 235-240 (2010).
47. Chen, L. et al. Structural basis of YAP recognition by TEAD4 in the Hippo pathway. Genes Dev. 24, 290-300 (2010).
48. Yu, F. X. & Guan, K. L. The Hippo pathway: regulators and regulations. Genes Dev. 27, 355-371 (2013).
49. DeRan, M. et al. Energy stress regulates Hippo-YAP signaling involving AMPKmediated regulation of angiomotin-like 1 protein. Cell Rep. 9, 495-503 (2014).
50. Zhang, H. et al. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition. J. Biological Chem. 284, 13355-13362 (2009).
51. Wang, W. et al. AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat. Cell Biol. 17, http://dx.doi.org/10.1038/ncb3113 (2015).